Rigel Pharmaceuticals (RIGL) Q3 2024 Earnings

6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.5
-0.33
-0.17
0

Details

Expected EPS
-0.292098
Actual EPS
-0.06
Surprise EPS
0.23
Surprise Percent
+79.46%

Description

Rigel Pharmaceuticals (RIGL) has reported earnings of -0.06 per share for Q3 2024.

0 Comments

Share your thoughts